[HTML][HTML] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - Plos one, 2019 - journals.plos.org
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - Plos one, 2019 - europepmc.org
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

[PDF][PDF] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - PLoS ONE, 2019 - academia.edu
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

[引用][C] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - PLoS ONE, 2019 - ui.adsabs.harvard.edu
Inappropriate prescribing defined by STOPP and START criteria and its association with
adverse drug events among hospitalized older patients: A multicentre, prospective study …

Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, N Abd Aziz… - PloS one, 2019 - pubmed.ncbi.nlm.nih.gov
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

[HTML][HTML] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, N Abd Aziz, Y Hassan - PLoS ONE, 2019 - ncbi.nlm.nih.gov
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - PLoS ONE, 2019 - search.ebscohost.com
Objectives: To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

[PDF][PDF] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz… - PLoS ONE, 2019 - pdfs.semanticscholar.org
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

[PDF][PDF] Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, NA Aziz, Y Hassan - PLoS ONE, 2019 - researchgate.net
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …

Inappropriate prescribing defined by STOPP and START criteria and its association with adverse drug events among hospitalized older patients: A multicentre …

ML Fahrni, MT Azmy, E Usir, N Abd Aziz, Y Hassan - PLoS ONE, 2019 - go.gale.com
Objectives To provide baseline information on inappropriate prescribing (IP), and to
evaluate whether potentially inappropriate medications (PIMs), as defined by STOPP …